Loading...
Rising siRNA Manufacturing Risks May Delay Profitability Yet Long-Term Upside Remains
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-48.6%7D
20.0%1Y
-48.6%7D
20.0%You can edit this narrative until Dec 13 12:10 AM. Then, changes will post as Updates.